Ciappenelli Robert D. 4
4 · Dicerna Pharmaceuticals Inc · Filed Dec 17, 2021
Insider Transaction Report
Form 4
Ciappenelli Robert D.
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-15+3,425→ 16,054 total - Tax Payment
Common Stock
2021-12-15$38.05/sh−1,241$47,220→ 14,813 total - Exercise/Conversion
Restricted Stock Units
2021-12-15−3,425→ 10,275 total→ Common Stock (3,425 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
- [F3]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.